Abiopharma

News list

📋 Congleton Jon (Officer) plans to sell 16K shares of Mineralys Therapeutics, Inc. (at $32.62 each, total $530K) Filed: Jan 12, 2026 | ID: 000036

Full text

News bot Jan. 12, 2026, 9:25 p.m.
📋 Form 144 Filing: Congleton Jon

Company: Mineralys Therapeutics, Inc.

Filing Date: 2026-01-12

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 16,236
- Price per Share: $32.62
- Total Value: $529,639.50
- Planned Sale Date: 2026-01-12
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41614
- Issuer Contact Phone: (888) 378-6240
- Issuer Address: 150 N. RADNOR CHESTER RD., SUITE F200, RADNOR, PA, 19087
- Broker Address: 225 Liberty St, Floor 37, New York, NY, 10281
- Shares Outstanding: 79139956.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: Jon Congleton